Total Payments
$40,888
2024 Payments
$89.35
Companies
31
Transactions
314
Medicare Patients
2,217
Medicare Billing
$872,301
Payment Breakdown by Category
Other$33,490 (81.9%)
Food & Beverage$5,150 (12.6%)
Travel$1,976 (4.8%)
Education$271.14 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $33,490 | 21 | 81.9% |
| Food and Beverage | $5,150 | 229 | 12.6% |
| Travel and Lodging | $1,976 | 6 | 4.8% |
| Education | $271.14 | 58 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| US WorldMeds, LLC | $24,905 | 70 | $0 (2020) |
| Alkermes, Inc. | $5,691 | 32 | $0 (2023) |
| Indivior Inc. | $5,427 | 23 | $0 (2024) |
| Collegium Pharmaceutical, Inc. | $3,125 | 104 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $399.73 | 28 | $0 (2022) |
| ABBVIE INC. | $174.87 | 6 | $0 (2024) |
| Grifols USA, LLC | $165.73 | 1 | $0 (2017) |
| ASSERTIO THERAPEUTICS, Inc. | $123.67 | 7 | $0 (2019) |
| Averitas Pharma Inc. | $120.13 | 2 | $0 (2023) |
| Allergan, Inc. | $103.46 | 7 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $89.35 | 3 | ABBVIE INC. ($65.41) |
| 2023 | $404.54 | 15 | Averitas Pharma Inc. ($120.13) |
| 2022 | $383.67 | 17 | Alkermes, Inc. ($121.20) |
| 2021 | $224.87 | 12 | Indivior Inc. ($55.62) |
| 2020 | $427.72 | 29 | US WorldMeds, LLC ($132.51) |
| 2019 | $20,120 | 92 | US WorldMeds, LLC ($14,394) |
| 2018 | $11,204 | 99 | US WorldMeds, LLC ($10,378) |
| 2017 | $8,034 | 47 | Alkermes, Inc. ($5,233) |
All Payment Transactions
314 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/27/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $32.33 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 03/22/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $33.08 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 01/23/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $23.94 | General |
| Category: OUD | ||||||
| 09/29/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $27.42 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/27/2023 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: Neurology | ||||||
| 07/13/2023 | Forte Bio-Pharma LLC | NALOCET (Drug), PROLATE, PROLATE | Food and Beverage | In-kind items and services | $32.25 | General |
| Category: PAIN | ||||||
| 06/29/2023 | Alkermes, Inc. | Vivitrol (Drug) | Food and Beverage | In-kind items and services | $20.18 | General |
| Category: CNS | ||||||
| 06/23/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $32.06 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 06/08/2023 | Alkermes, Inc. | Vivitrol (Drug) | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: CNS | ||||||
| 06/08/2023 | Alkermes, Inc. | Vivitrol (Drug) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: CNS | ||||||
| 05/13/2023 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $28.16 | General |
| Category: PAIN MANAGEMENT | ||||||
| 04/20/2023 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $24.02 | General |
| Category: Opioid Analgesic | ||||||
| 04/14/2023 | Alkermes, Inc. | Vivitrol (Drug) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: CNS | ||||||
| 04/07/2023 | DePuy Synthes Sales Inc. | ORTHOVISC (Device) | Food and Beverage | In-kind items and services | $25.77 | General |
| Category: Sports Early Intervention | ||||||
| 04/06/2023 | DePuy Synthes Sales Inc. | ORTHOVISC (Device) | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: Sports Early Intervention | ||||||
| 03/16/2023 | Almatica Pharma LLC | GRALISE (Drug) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: POSTHERPETIC NEURALGIA | ||||||
| 03/02/2023 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $91.97 | General |
| Category: PAIN MANAGEMENT | ||||||
| 02/24/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $30.94 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/15/2022 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $24.30 | General |
| Category: CNS | ||||||
| 11/16/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: Gastroenterology | ||||||
| 11/10/2022 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: CNS | ||||||
| 11/02/2022 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $13.05 | General |
| Category: OUD | ||||||
| 09/29/2022 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: CNS | ||||||
| 09/29/2022 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $1.63 | General |
| Category: CNS | ||||||
| 09/26/2022 | Alkermes, Inc. | VIVITROL (Drug) | Education | In-kind items and services | $14.85 | General |
| Category: CNS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 485 | 2,295 | $435,474 | $194,106 |
| 2022 | 8 | 512 | 2,660 | $505,477 | $229,501 |
| 2021 | 10 | 612 | 2,735 | $528,543 | $243,221 |
| 2020 | 11 | 608 | 3,728 | $500,483 | $205,473 |
Total Patients
2,217
Total Services
11,418
Medicare Billing
$872,301
Procedure Codes
37
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 232 | 1,718 | $257,700 | $141,111 | 54.8% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2023 | 70 | 199 | $79,600 | $19,393 | 24.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 62 | 62 | $21,554 | $9,628 | 44.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 39 | 62 | $12,400 | $7,264 | 58.6% |
| J7323 | Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | Office | 2023 | 13 | 56 | $16,800 | $5,681 | 33.8% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2023 | 37 | 104 | $10,920 | $5,252 | 48.1% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2023 | 21 | 83 | $33,200 | $4,599 | 13.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 11 | 11 | $3,300 | $1,177 | 35.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 266 | 2,071 | $310,588 | $176,075 | 56.7% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2022 | 70 | 187 | $74,800 | $18,632 | 24.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 54 | 54 | $18,900 | $8,653 | 45.8% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2022 | 37 | 135 | $14,175 | $7,248 | 51.1% |
| 62370 | Electronic analysis reprogramming and refill of spinal canal drug infusion pump by physician | Office | 2022 | 13 | 69 | $41,075 | $6,505 | 15.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 24 | 44 | $8,750 | $5,400 | 61.7% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2022 | 21 | 73 | $29,089 | $4,128 | 14.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 27 | 27 | $8,100 | $2,860 | 35.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 260 | 2,083 | $312,450 | $179,550 | 57.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 103 | 103 | $36,050 | $16,417 | 45.5% |
| 20611 | Aspiration and/or injection of major joint or joint capsule with recording and reporting using ultrasound guidance | Office | 2021 | 75 | 149 | $59,600 | $14,929 | 25.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 58 | 73 | $15,050 | $8,609 | 57.2% |
| 62370 | Electronic analysis reprogramming and refill of spinal canal drug infusion pump by physician | Office | 2021 | 12 | 77 | $46,200 | $7,639 | 16.5% |
| 20552 | Injections of trigger points in 1 or 2 muscles | Office | 2021 | 40 | 103 | $10,815 | $5,557 | 51.4% |
| 76942 | Ultrasonic guidance imaging supervision and interpretation for insertion of needle | Office | 2021 | 25 | 94 | $37,600 | $5,387 | 14.3% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 13 | 26 | $5,200 | $2,550 | 49.0% |
| 95910 | Nerve transmission studies, 7-8 studies | Office | 2021 | 13 | 13 | $5,200 | $2,407 | 46.3% |
About Dr. Thomas Jan, D.O
Dr. Thomas Jan, D.O is a Neuromusculoskeletal Medicine & OMM healthcare provider based in Massapequa, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1871685404.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Jan, D.O has received a total of $40,888 in payments from pharmaceutical and medical device companies, with $89.35 received in 2024. These payments were reported across 314 transactions from 31 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($33,490).
As a Medicare-enrolled provider, Jan has provided services to 2,217 Medicare beneficiaries, totaling 11,418 services with total Medicare billing of $872,301. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Ad
Practice Information
- Specialty Neuromusculoskeletal Medicine & OMM
- Other Specialties Pain Medicine, Interventional Pain Medicine
- Location Massapequa, NY
- Active Since 09/29/2006
- Last Updated 04/04/2011
- Taxonomy Code 204D00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1871685404
Products in Payments
- Lucemyra/Lofexidine (Drug) $24,831
- SUBLOCADE (Drug) $5,427
- Vivitrol 380 mg (Drug) $5,312
- Xtampza ER (Drug) $2,482
- XTAMPZA (Drug) $430.34
- VIVITROL (Drug) $260.42
- BOTOX (Biological) $249.17
- RELISTOR (Drug) $218.58
- Thrombate III (Biological) $165.73
- RELISTOR ORAL (Drug) $152.59
- QUTENZA (Drug) $120.13
- Vivitrol (Drug) $118.40
- LUCEMYRA (Drug) $81.55
- ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH (Drug) $80.62
- Lucemyra (Drug) $73.98
- ORTHOVISC (Device) $73.98
- Zipsor (Drug) $69.04
- XtampzaER (Drug) $61.44
- CAM2038 $47.00
- XTAMPZA ER (Drug) $44.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.